Artificial sweeteners - Do they bear a carcinogenic risk?

Annals of Oncology

Volumn 15, Issue 10, 2004, Pages 1460-1465

  Weihrauch, Martin R ^a,b   Diehl, V ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Aspartame; Cancer; Cyclamate; Saccharin; Sweeteners

Indexed keywords

ACESULFAME; ALITAME; ASPARTAME; CYCLAMATE SODIUM; NEOTAME; SACCHARIN; SUCRALOSE; SWEETENING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLADDER CANCER; CANCER RESEARCH; CANCER RISK; CARCINOGENICITY; CASE CONTROL STUDY; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; HUMAN; LIBRARY; MEDLINE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ASPARTAME; CASE-CONTROL STUDIES; CYCLAMATES; EPIDEMIOLOGIC STUDIES; HUMANS; NEOPLASMS; RISK FACTORS; SACCHARIN; SWEETENING AGENTS;

EID: 6944239873     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh256     Document Type: Review

References (48)

1. Maone TR, Mattes RD, Bernbaum JC, Beauchamp GK. A new method for delivering a taste without fluids to preterm and term infants. Dev Psychobiol 1990; 23: 179-191.
2. Bright G. Low-calorie sweeteners - from molecules to mass markets. World Rev Nutr Diet 1999; 85: 3-9.
3. Anonymous. FDA extends ban on cyclamates. Science 1970; 169: 962.
4. Lindley MG. New developments in low-calorie sweeteners. World Rev Nutr Diet 1999; 85: 44-51.
5. Fukushima S, Arai M, Nakanowatari J et al. Differences in susceptibility to sodium saccharin among various strains of rats and other animal species. Gann 1983; 74: 8-20.
6. Whysner J, Williams GM. Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 1996; 71: 225-252.
7. Taylor JM, Weinberger MA, Friedman L. Chronic toxicity and carcinogenicity to the urinary bladder of sodium saccharin in the in utero-exposed rat. Toxicol Appl Pharmacol 1980; 54: 57-75.
8. Squire RA. Histopathological evaluation of rat urinary bladders from the IRDC two-generation bioassay of sodium saccharin. Food Chem Toxicol 1985; 23: 491-497.
9. Cohen SM, Anderson TA, de Oliveira LM, Arnold LL. Tumorigenicity of sodium ascorbate in male rats. Cancer Res 1998; 58: 2557-2561.
10. Takayama S, Sieber SM, Adamson RH et al. Long-term feeding of sodium saccharin to nonhuman primates: implications for urinary tract cancer. J Natl Cancer Inst 1998; 90: 19-25.
11. Jacobson MF, Farber E, Clapp R. Re: Long-term feeding of sodium saccharin to nonhuman primates: implications for urinary tract cancer. J Natl Cancer Inst 1998; 90: 934-936.
12. Armstrong B, Doll R. Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharin consumption. Br J Prev Soc Med 1974; 28: 233-240.
13. Armstrong B, Doll R. Bladder cancer mortality in diabetics in relation to saccharin consumption and smoking habits. Br J Prev Soc Med 1975; 29: 73-81.
14. Jensen OM, Kamby C. Intra-uterine exposure to saccharin and risk of bladder cancer in man. Int J Cancer 1982; 29: 507-509.
15. Yu Y, Hu J, Wang PP et al. Risk factors for bladder cancer: a case-control study in northeast China [published erratum appears in Eur J Cancer Prev 1998; 7: 171]. Eur J Cancer Prev 1997; 6: 363-369.
16. Brennan P, Bogillot O, Cordier S et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000; 86: 289-294.
17. Mikhailidis DP, Ganotakis ES, Papadakis JA, Jeremy JY. Smoking and urological disease. J R Soc Health 1998; 118: 210-212.
18. Teschke K, van Zwieten L. Perceptions of the causes of bladder cancer, nasal cancer, and mesothelioma among cases and population controls. Appl Occup Environ Hyg 1999; 14: 819-826.
19. Bopp BA, Sonders RC, Kesterson JW. Toxicological aspects of cyclamate and cyclohexylamine. Crit Rev Toxicol 1986; 16: 213-306.
20. Wagner MW. Cyclamate acceptance. Science 1970; 168: 1605.
21. Takayama S, Renwick AG, Johansson SL et al. Long-term toxicity and carcinogenicity study of cyclamate in nonhuman primates. Toxicol Sci 2000; 53: 33-39.
22. Renwick AG. The metabolism of intense sweeteners. Xenobiotica 1986; 16: 1057-1071.
23. Gaunt IF, Sharratt M, Grasso P et al. Short-term toxicity of cyclohexylamine hydrochloride in the rat. Food Cosmet Toxicol 1974; 12: 609-624.
24. James RW, Heywood R, Crook D. Testicular responses of rats and dogs to cyclohexylamine overdosage. Food Cosmet Toxicol 1981; 19: 291-296.
25. Roberts A, Renwick AG. The pharmacokinetics and tissue concentrations of cyclohexylamine in rats and mice. Toxicol Appl Pharmacol 1989; 98: 230-242.
26. Roberts A, Renwick AG, Ford G et al. The metabolism and testicular toxicity of cyclohexylamine in rats and mice during chronic dietary administration. Toxicol Appl Pharmacol 1989; 98: 216-229.
27. Huff J, Tomatis L. Re: Long-term toxicity and carcinogenicity study of cyclamate in nonhuman primates (Takayama.Toxicol Sci. 53, 33-39). Toxicol Sci 2000; 57: 186.
28. Hagiwara A, Fukushima S, Kitaori M et al. Effects of three sweeteners on rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Gann 1984; 75: 763-768.
29. Ishii H. Incidence of brain tumors in rats fed aspartame. Toxicol Lett 1981; 7: 433-437.
30. Jeffrey AM, Williams GM. Lack of DNA-damaging activity of five non-nutritive sweeteners in the rat hepatocyte/DNA repair assay. Food Chem Toxicol 2000; 38: 335-338.
31. Olney JW, Farber NB, Spitznagel E, Robins LN. Increasing brain tumor rates: is there a link to aspartame? J Neuropathol Exp Neurol 1996; 55: 1115-1123.
32. Study E33-34 in Master file 134 on aspartame. On file at the FDA Hearing Clerk's Office 2001.
33. Shephard SE, Wakabayashi K, Nagao M. Mutagenic activity of peptides and the artificial sweetener aspartame after nitrosation. Food Chem Toxicol 1993; 31: 323-329.
34. Schwabe U. Health risk caused by sugar substitutes. Internist (Berl) 1998; 39: 869.
35. Ross JA. Brain tumors and artificial sweeteners? A lesson on not getting soured on epidemiology. Med Pediatr Oncol 1998; 30: 7-8.
36. Anonymous. Aspartame. Review of safety issues. Council on Scientific Affairs. JAMA 1985; 254: 400-402.
37. Gurney JG, Pogoda JM, Holly EA. Aspartame consumption in relation to childhood brain tumor risk: results from a case-control study [published erratum appears in J Natl Cancer Inst 1997; 89: 1460]. Natl Cancer Inst 1997; 89: 1072-1074.
38. Schwartz GR. Aspartame and breast and other cancers [published erratum appears in West J Med 2000; 172: 233]. West J Med 1999; 171: 300-301.
39. Adami HO, Signorello LB, Trichopoulos D. Towards an understanding of breast cancer etiology. Semin Cancer Biol 1998; 8: 255-262.
40. Trichopoulos D. Response. West J Med 1999; 171: 301.
41. Chu KC, Tarone RE, Kessler LG et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996; 88: 1571-1579.
42. Simon D, Yen S, Cole P. Coffee drinking and cancer of the lower urinary tract. J Natl Cancer Inst 1975; 54: 587-591.
43. Wynder EL, Goldsmith R. The epidemiology of bladder cancer: a second look. Cancer 1977; 40: 1246-1268.
44. Wynder EL, Stellman SD. Artificial sweetener use and bladder cancer: a case-control study. Science 1980; 207: 1214-1216.
45. Morrison AS, Buring JE. Artificial sweeteners and cancer of the lower urinary tract. N Engl J Med 1980; 302: 537-541.
46. Piper JM, Matanoski GM, Tonascia J. Bladder cancer in young women. Am J Epidemiol 1986; 123: 1033-1042.
47. Cartwright RA, Adib R, Glashan R, Gray BK. The epidemiology of bladder cancer in West Yorkshire. A preliminary report on non-occupational aetiologies. Carcinogenesis 1981; 2: 343-347.
48. Sturgeon SR, Hartge P, Silverman DT et al. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994; 5: 218-225.